Ambiq Micro adds SGX listing, expands Singapore R&D
The US-listed edge AI chip designer seeks to offer Asian investors direct access while committing to a multi-year research and development programme in Singapore.
SGX Secondary Listing for Asian Access
Ambiq Micro, an edge artificial intelligence (AI) chip designer, has completed a secondary listing on the Singapore Exchange (SGX). This move, according to CEO Fumihide Esaka, demonstrates the company's commitment to Singapore and the wider Asia-Pacific region. The listing also aims to provide Asian investors with more direct avenues to invest in the firm.
Ambiq Micro currently trades on the New York Stock Exchange, where its initial public offering (IPO) in July 2025 raised US$96 million. The SGX listing did not involve issuing new shares, strategically preserving flexibility for future capital raises.
Expanding Singapore Operations and R&D
The company plans to expand its research and development (R&D) team in Singapore, investing further in local engineering capabilities. This includes a multi-year R&D programme for its power-efficient Spot platform, supported by the Singapore Economic Development Board (EDB).
Ambiq Micro established its Asia-Pacific headquarters in Singapore in 2021, followed by an R&D centre in 2025. The firm currently employs over 30 staff in Singapore, though specific headcount targets for the expansion were not disclosed by Esaka.
Financials and Market Outlook
Ambiq Micro's net sales for the first quarter of 2026 reached US$25.1 million, marking a 59.3 per cent increase year-on-year from US$15.7 million. However, losses also rose during the same period, climbing to US$10.2 million from US$8.3 million a year earlier.
The company secured US$179.4 million in a capital raise in July 2026, which Esaka stated leaves the company "sufficiently capitalised" for now. Esaka anticipates continued strong growth in the AI and edge AI market, noting that demand for new product capabilities from customers is accelerating.
Ambiq Micro's dual-listing strategy and R&D expansion highlight Singapore's increasing importance as a hub for technology investment and innovation in Asia. The move offers regional investors a local entry point into the growing edge AI sector, driven by rising demand for power-efficient chips in consumer devices.
For Ambiq, Singapore's talent pool and intellectual property protections support its global product development efforts. Future capital raises in Singapore could fund further scaling of its engineering teams, addressing the company's focus on faster product delivery.
This article is journalism, not investment advice; consult a licensed professional before making financial decisions. Market data is indicative, may be delayed, and should be verified with your broker or exchange before use.
Comments.
Comments are moderated. We remove what is unlawful, abusive or off-topic, and and you remain responsible for what you post.
Reader comments open soon. Until then, corrections and responses go to our newsroom, and we publish what we get wrong on Corrections.